After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, VOR falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Vor Biopharma Inc is $36.24M. A total of 36.69 million shares were traded on the day, compared to an average of 2.23M shares.
In the most recent transaction, Attar Eyal C. sold 2,227 shares of VOR for 1.42 per share on Feb 13 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 126,625 company shares. In a previous transaction on Feb 13 ’25, EYAL ATTAR bought 2,227 shares at 1.38 per share.
Among the insiders who sold shares, Attar Eyal C. disposed of 2,554 shares on Feb 10 ’25 at a per-share price of $1.37. This resulted in the CHIEF MEDICAL OFFICER holding 128,852 shares of VOR after the transaction. In another insider transaction, EYAL ATTAR bought 2,554 shares at $1.41 per share on Feb 10 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, VOR has a high of $1.80 and a low of $0.13.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VOR’s latest balance sheet shows that the firm has $207.47M in Cash & Short Term Investments as of fiscal 2021. There were $18.01M in debt and $10.15M in liabilities at the time. Its Book Value Per Share was $0.53, while its Total Shareholder’s Equity was $216.26M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VOR is Buy with a score of 3.00.
